Utilidad del índice de masa corporal y de la glucemia como factores de mal pronóstico en pacientes con fibromas blandos.

Abstract

Soft fibromas are known benign skin tumors that are a frequent reason for consultation. These are pedunculated skin lesions that can be single or multiple, whose evolution is measured by the increase in their number, size and change in color. These are usually benign in nature with almost no risk of malignancy and are usually seen in conjunction with diseases. metabolic. The purpose of the study is to evaluate the effect of glycemia levels and BMI as prognostic factors on the development of the condition in patients at the Dr. Teodoro Maldonado Carbo Specialty Hospital in the period 2012-2019. The study is quantitative, correlational and longitudinal in nature. The universe was taken as all patients who attended the dermatology outpatient clinic with soft fibroids in the period 2012-2019. BMI and blood glucose were recorded and the number of fibroids was counted. Data were tabulated in Microsoft Excel and statistical analysis was performed using SPSS. From a universe of 4006 cases, patients were filtered through inclusion and exclusion criteria, leaving a total of 265 cases. In the study, normoglycemic patients more frequently had an increase in the number of fibroids in relation to dysglycemic and hyperglycemic patients (59.6% vs. 40.4%). These relationships were not statistically significant. Mean age and BMI were not significantly different between those with or without a change in the number of fibroids. In conclusion, the results indicated that glycemia and BMI levels do not constitute poor prognostic factors in patients with soft fibroids since an increase in their number was not observed.